Form 4 for OM Outset Medical, Inc.
Accepted 2026-05-18 09:53:35 ET · period of report 2026-05-15 · accession 0001373604-26-000043 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-05-18 09:53 | 2026-05-15 | OM | Leonard Braden Michael | 10% | X - OptEx | $5.00 | +323.0K | 2.52M | +15% | +$1.61M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | X | A | 323,000 | $5.00 | 2,519,701 | I Holdings of BML Investment Partners, L.P. | — | — | (F2) The reporting owner was short June, 2026 put options and these shares were assigned on expiration. (F1) BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. |